Association between Endothelial nitric oxide synthase and Hepatic lipase gene polymorphisms with the risk of coronary artery disease in Southern Iran population - A case control study.
Seyed Masoud SeyedianMahdi BijanzadehFarzaneh AhmadiMohammad Hosein HaghighizadehPublished in: Nucleosides, nucleotides & nucleic acids (2021)
Coronary artery disease is a multifactorial genetic disease caused by the interaction between genetic and environmental factors. Angiography is the gold standard method for the diagnosis and determining the stage of cardiac disorder. The rs1800588 at the Hepatic Lipase gene and rs1799983 at the endothelial nitric oxide synthase (eNOS) gene are two candidate SNP that result in increased risk of this disease. The aim of this study was to find out the associations of the two mentioned polymorphisms with angiographically proven coronary artery patients in a southern Iranian population. In this study, this two polymorphisms in 287 patients and 229 matched controls were confirmed by angiography and analyzed. Genotype analysis was carried out by PCR and RFLP. Data showed that a significant difference for the eNOS gene polymorphism (p = 0.004) and a non-significant difference for the Hepatic lipase polymorphism (p = 0.261) and increasing severity of angiographic evidences of coronary artery disease were observed. Conclusively the significant association of the G894T with the narrowing of two or three coronary vessels of this patients in an Iranian population have been detected.
Keyphrases
- coronary artery disease
- nitric oxide synthase
- coronary artery
- ejection fraction
- end stage renal disease
- nitric oxide
- newly diagnosed
- genome wide
- optical coherence tomography
- heart failure
- computed tomography
- type diabetes
- cardiovascular disease
- pulmonary artery
- gene expression
- machine learning
- acute coronary syndrome
- left ventricular
- aortic stenosis
- atrial fibrillation
- pulmonary hypertension
- signaling pathway
- transcription factor
- artificial intelligence
- aortic valve